Evidence map›Paper›PMID 40956824›Full record

ArticlePloS one2025

Prevalence and clustering of cardiovascular risk factors in a population aged 25-64 in Czechia: A cross-sectional study.

Juraj Michalec, Michala Lustigová, Anna Frűhaufová, Šárka Malá, Pavlína Krollová, Kristýna Žejglicová, Jana Malinovská, Lucia Bučková, Marika Koželuhová, Palavi Gupta and 5 more

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Juraj MichalecDepartment of Internal Medicine, University Hospital Motol, Second Faculty of Medicine, Charles University, Prague, Czech Republic.ORCID 0009-0006-5484-3742
Michala LustigováDepartment of Social Geography and Regional Development, Faculty of Science, Charles University, Prague, Czech Republic.ORCID 0000-0002-5235-1932
Anna FrűhaufováDepartment of General Practice, Second Faculty of Medicine of Charles University, Prague, Czech Republic.
Šárka MaláDepartment of Internal Medicine, University Hospital Motol, Second Faculty of Medicine, Charles University, Prague, Czech Republic.ORCID 0000-0001-9474-3734
Pavlína KrollováDepartment of Internal Medicine, University Hospital Motol, Second Faculty of Medicine, Charles University, Prague, Czech Republic.
Kristýna ŽejglicováThe National Institute of Public Health, Prague, Czech Republic.
Jana MalinovskáDepartment of Internal Medicine, University Hospital Motol, Second Faculty of Medicine, Charles University, Prague, Czech Republic.ORCID 0000-0002-3846-7509
Lucia BučkováDepartment of Internal Medicine, University Hospital Motol, Second Faculty of Medicine, Charles University, Prague, Czech Republic.
Marika KoželuhováDepartment of Internal Medicine, University Hospital Motol, Second Faculty of Medicine, Charles University, Prague, Czech Republic.
Palavi GuptaDepartment of Internal Medicine, University Hospital Motol, Second Faculty of Medicine, Charles University, Prague, Czech Republic.
Pankhuri JainDepartment of Internal Medicine, University Hospital Motol, Second Faculty of Medicine, Charles University, Prague, Czech Republic.
Natália MichalcováDepartment of Internal Medicine, University Hospital Motol, Second Faculty of Medicine, Charles University, Prague, Czech Republic.
Veronika PuchnerováDepartment of Cardiology, University Hospital Motol, Second Faculty of Medicine, Charles University, Prague, Czech Republic.
Matthew CampbellFaculty of Health Science and Wellbeing, University of Sunderland, Sunderland, United Kingdom.
Jan BrožDepartment of Internal Medicine, University Hospital Motol, Second Faculty of Medicine, Charles University, Prague, Czech Republic.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCardiovascular events are still the most common cause of death in the Czech Republic. The increasing prevalence of risk factors such as dyslipidaemia, hypertension, obesity, and diabetes individually and collectively contribute to cardiovascular events. The aim of this study was to determine their prevalence and interrelationships.

methodThe data for this epidemiological study were obtained from the Czech cross-sectional study EHES 2019 (European Health Examination Survey) with stratified random sampling. Firstly, individual risk factors (dyslipidaemia, hypertension, obesity, diabetes, and smoking) in population aged 25-64 years of age were monitored using questionnaires and physical and laboratory measurements; additionally, the cumulative effect of these risk factors in subjects was examined. Finally, cardiovascular risk in the age group of 40-64 years (767 out of 1057 participants) was estimated using the SCORE EU chart (for countries with high cardiovascular risk). Individual parameters were assessed according to standard criteria: dyslipidaemia = total cholesterol ≥5.0 mmol/l, and/or HDL-C < 1.0 mmol/l in men, or <1.2 mmol/l in women, and/or LDL-C ≥ 3.0 mmol/l and/or fasting TAG ≥ 1.7 mmol/l (or ≥2 mmol/l without fasting) and/or medication with lipid-lowering drugs; obesity = BMI > 30 kg/m2; hypertension = systolic blood pressure ≥ 140 mmHg, and/or diastolic blood pressure ≥ 90 mmHg, and/or antihypertensive treatment; diabetes mellitus = HbA1c ≥ 48 mmol/mol and/or on treatment. Data were analysed by descriptive statistics.

resultsOf the total number of 1057 study participants (426 men and 631 women) aged 25-64 years, roughly 84% presented with ≥1 cardiovascular disease risk factor. The most common risk factor was dyslipidaemia, which occurred in 71.7% of the subjects. The prevalence of hypertension was 36.3% (men 46.0%, women 26.3%). 29.7% of subjects were obese, diabetes mellitus occurred in 5.7% (men 7.6%, women 3.7%). 17.7% were regular smokers; another 6.6% reported occasional smoking. A combination of risk factors was common, e.g., 77.3% had dyslipidaemia and/or hypertension. There were 16.1% of subjects without monitored cardiovascular risk factors. After stratification of cardiovascular risk prediction according to SCORE chart, 49.7% of individuals fall into low risk, 28.6% into medium risk, and up to 11.3% into high and 10.4% into very high risk.

conclusionThe most common risk factor is lipid spectrum disorders (71.7%). Combination of risk factors is common, which increases the risk of cardiovascular events in these individuals. In the 40-64 age group, 21.7% of the population is at >5% risk of a fatal cardiovascular event over the next 10 years.

Indexed as

Cardiovascular DiseasesHeart Disease Risk FactorsAdultCross-Sectional StudiesCzech RepublicDiabetes MellitusDyslipidemiasFemaleHumansHypertensionMaleMiddle AgedObesityPrevalenceRisk Factors

Identifiers

PMID40956824
PMCPMC12440201

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.